OakChart

Sensus Healthcare Inc

SRTSHealthcare·Medical Devices·USA·Micro·NASD·Nov 11 • 12:07 PM ET

3.40+0.10 (3.03%)
2026-11-11 18:08 CET
Market cap
54.32 USD m
Revenue, TTM
17.51 USD m
Net income, TTM
-15.48 USD m
Free cash flow, TTM
-6.97 USD m
EPS diluted, TTM
-0.94
P/E
-
Compare

Price

SRTS against its 20, 50 and 200-day averages
2050200missearnings
3.004.005.004.9M9.7MMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26SRTSclose 3.4020-day 2.9350-day 3.00200-day 3.463.4052w low

38.1% under the 52-week high of 5.49 on 13 Jan 2026. 52-week low 2.66 on 1 Jun 2026. Last 15 sessions, 95.9% high to low

Profile

SRTS
52-week range, 26% of the way up
2.665.49

Sensus Healthcare, Inc. is a medical device company, which engages in the provision of treatment for both oncological and non-oncological skin conditions. The company was founded by Joseph C. Sardano, Richard Golin, Kalman Fishman, and Stephen Cohen on May 7, 2010 and is headquartered in Boca Raton, FL.

Employees60
IPOJul 26, 2016
Beta1.24
ATR, 14d0.35
Rel volume0.05
Short float1.66%
Insider own18.67%
Inst own25.14%

Snapshot

6 groups

Valuation

Index-
Market Cap55.97M
Enterprise Value41.12M
Income-15.48M
Sales17.51M
Book/sh2.24
Cash/sh0.92
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees60
IPOJul 26, 2016

Ratios

P/E-
Forward P/E-
PEG-
P/S3.20
P/B1.52
P/C3.68
P/FCF-
EV/EBITDA-
EV/Sales2.35
Quick Ratio4.30
Current Ratio8.71
Debt/Eq0.01
LT Debt/Eq0.00
Option/ShortYes / Yes

Earnings

EPS (ttm)-0.94
EPS next Y-0.11
EPS next Q-0.06
EPS this Y-68.62%
EPS next Y85.80%
EPS next 5Y-
EPS past 3/5Y- -2.60%
Sales past 3/5Y-14.86% 23.47%
EPS Y/Y TTM-1719.88%
Sales Y/Y TTM-53.40%
EPS Q/Q-737.01%
Sales Q/Q-68.69%
EarningsNov 12 AMC
EPS/Sales Surpr.-324.00% -50.23%

Ownership

Insider Own18.67%
Insider Trans5.95%
Inst Own25.14%
Inst Trans-4.26%
ROA-30.94%
ROE-34.83%
ROIC-41.93%
Gross Margin36.39%
Oper. Margin-75.72%
Profit Margin-88.45%
SMA2015.97%
SMA5013.48%
SMA200-1.76%
Trades-

Technical

Shs Outstand16.46M
Shs Float13.39M
Short Float1.66%
Short Ratio1.14
Short Interest0.22M
52W High5.49 -38.07%
52W Low2.66 27.82%
Volatility16.94% 11.84%
ATR (14)0.35
RSI (14)64.20
Beta1.24
Rel Volume0.05
Avg Volume194.57K
Volume4,268

Performance

Perf Week4.62%
Perf Month17.65%
Perf Quarter7.59%
Perf Half Y-1.45%
Perf YTD-14.57%
Perf Year-19.24%
Perf 3Y78.95%
Perf 5Y-28.57%
Perf 10Y-43.72%
Recom1.00
Target Price5.38
Prev Close3.30
Price3.40
Change %3.03%

Analyst ratings

latest 10 of 13
DateActionAnalystRating changeTargetImplied
Mar 06, 2026InitiatedAAlliance Global PartnersBuy$7.50+120.6%
Jan 31, 2025InitiatedLLake StreetBuy$18+429.4%
Nov 15, 2024ReiteratedMMaxim GroupBuy$12 → $14+311.8%
Feb 26, 2021UpgradeNNorthland CapitalMarket Perform → Outperform
Dec 16, 2020DowngradeNNorthland CapitalOutperform → Market Perform
Aug 10, 2020UpgradeAAlliance Global PartnersNeutral → Buy$2.40 → $4.25+25.0%
Feb 14, 2020UpgradeAAlliance Global PartnersNeutral → Buy$6+76.5%
Nov 07, 2019DowngradeBB. Riley FBRBuy → Neutral$14 → $5.50+61.8%
Jan 29, 2019DowngradeNNorthland CapitalMarket Perform → Under Perform
Sep 26, 2018InitiatedBB. Riley FBRBuy$12.50+267.6%

Peers

Mkt cap
TickerCompanyMkt cap
ARAYAccuray Inc9.96M
ITOCiTonic Holdings Ltd15.65M
APYXApyx Medical Corp123.42M
VREXVarex Imaging Corp783.69M
INMDInmode Ltd771.09M
IRIXIRIDEX Corp11.42M
BFRIBiofrontera Inc13.88M
CATXPerspective Therapeutics Inc96.67M
DERMJourney Medical Corp126.16M
PLSEPulse Biosciences Inc4.14B

Insider trading

14 filings
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Sachetta EricDirectorAug 28 '26Buy3.4437,537129,015267,480Aug 31 12:35 PM
Sachetta EricDirectorAug 31 '26Buy3.5427,30496,602294,784Aug 31 12:35 PM
Sachetta EricDirectorAug 27 '26Buy3.1810,92534,752229,943Aug 28 02:29 PM
Sachetta EricDirectorAug 26 '26Buy3.299,70831,930219,018Aug 28 02:29 PM
Sachetta EricDirectorAug 24 '26Buy3.2534,697112,904209,310Aug 25 09:26 AM
Sardano Joseph CCHIEF EXECUTIVE OFFICERAug 20 '26Buy3.0220,00060,4861,220,293Aug 24 04:00 PM
Sachetta EricDirectorAug 20 '26Buy3.1324,00075,072167,613Aug 24 03:08 PM
Sachetta EricDirectorAug 21 '26Buy3.257,00022,778174,613Aug 24 03:08 PM
Sachetta EricDirectorMay 12 '26Buy3.331,5005,002143,613May 12 01:53 PM
Sachetta EricDirectorFeb 24 '26Buy3.812,0007,620142,113Feb 26 09:25 AM
Sachetta EricDirectorNov 21 '25Buy3.937,00027,510140,113Nov 21 02:28 PM
Sachetta EricDirectorNov 13 '25Buy4.502,50011,250133,113Nov 20 02:03 PM
Sardano Joseph CCHIEF EXECUTIVE OFFICERNov 18 '25Buy4.0325,000100,7501,200,293Nov 19 09:34 AM
Sardano MichaelPRESIDENT AND GENERAL COUNSELNov 18 '25Buy3.801,0003,800118,839Nov 19 09:15 AM

Held by

AUM
TickerCompanyAUM
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
VXFVanguard Extended Market Index ETFAUM: 30.47B
DFASU.S. Small Cap Portfolio-ETF Class Shares-
DFSVUS Small Cap Value Portfolio ETF Class Shares-
IWCiShares Micro-Cap ETFAUM: 1.22B
DFACU.S. Core Equity 2 Portfolio-ETF Class Shares-
AVSCAvantis U.S Small Cap Equity ETFAUM: 3.23B
DFMCU.S. Micro Cap Portfolio ETF Class Shares-
DCORUS Core Equity 1 Portfolio ETF Class Shares-
DXUVUS Vector Equity Portfolio ETF Class Shares-

News

latest 14 of 204
  • Sensus Healthcare Announces Sale of 1,000th SRT System, Marking Significant Commercial Milestone (Business Wire)
  • Sensus Healthcare to Report Third Quarter 2026 Financial Results and Hold Business Update Conference Call on November 12, 2026 (Business Wire)
  • Sensus Healthcare Inc (SRTS) (Q2 2026) Earnings Call Highlights: Strong Pipeline and New CPT ... (GuruFocus.com)
  • Sensus Healthcare Reports Second Quarter 2026 Financial Results and Business Highlights (Business Wire) -9.49%
  • Sensus Healthcare to Report Second Quarter 2026 Financial Results and Hold Business Update Conference Call on August 13, 2026 (Business Wire)
  • Loading…
  • Sensus Healthcare Reports First Quarter 2026 Financial Results and Business Highlights (Business Wire) -25.06%
  • Sensus Healthcare to Report First Quarter 2026 Financial Results and Hold Business Update Conference Call on May 7, 2026 (Business Wire)
  • Sensus Healthcare Files Lawsuit Against SkinCure Oncology for Breach of Contract (Business Wire)
  • Sensus Healthcare Introduces Sensus Link, Brings Advanced Operating Capabilities to the SRT-100 Installed Base (Business Wire)
  • Sensus Launches Sensus Healthcare Financial Services to Facilitate Customer Acquisition of SRT Technology (Business Wire)
  • Sensus Healthcare Inc (SRTS) Q4 2025 Earnings Call Highlights: Navigating Challenges with ... (GuruFocus.com) -16.99%
  • Sensus Healthcare Q4 Earnings Call Highlights (MarketBeat)
  • Sensus Healthcare Reports Fourth Quarter 2025 Financial Results Highlighted by Publication of Dedicated CPT Codes for SRT to Treat Non-Melanoma Skin Cancer (Business Wire)

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-12--0.055--6.614
2026Q22026-08-13-0.530-0.125-0.5302.294.604
2026Q12026-05-07-0.160-0.125-0.1603.395.324
2025Q42026-02-12-0.190-0.070-0.1944.948.353
2025Q32025-11-06-0.060-0.095-0.0586.906.314
2025Q22025-08-07-0.0600.026-0.0647.329.305
2025Q12025-05-15-0.1600.034-0.1578.347.235
2024Q42025-02-050.0900.1240.09413.0710.855
2024Q32024-11-140.070-0.0100.0748.845.903
2024Q22024-08-080.1000.0230.0999.247.003
2024Q12024-05-090.140-0.0430.13910.664.683
2023Q42024-02-080.2600.1430.25912.5712.064
2023Q32023-11-09-0.090-0.018-0.0893.905.905
2023Q22023-08-03-0.020-0.076-0.0234.534.555
2023Q12023-05-03-0.1200.125-0.1173.4110.074
2022Q42023-02-090.1700.2300.17113.1112.985

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2018FY-0.140-0.163-0.14326.4325.86
2019FY-0.100-0.135-0.10527.2627.35
2020FY-0.420-0.600-0.4169.587.02
2021FY0.2500.0900.25027.0425.11
2022FY1.4601.5241.45944.5344.43
2023FY0.030-0.0880.03024.4123.89
2024FY0.4100.4340.40641.8139.43
2025FY-0.470-0.343-0.47027.4830.86
2026FY--0.793--19.13
2027FY--0.113--28.19
2028FY-0.050--34.99
2029FY-0.680--78.48

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q3S2026-10-284006.615.448.50
2026Q3S2026-08-163216.755.448.50
2026Q3S2026-08-144226.615.448.50
2026Q3S2026-08-134016.234.706.97
2026Q3S2026-07-294016.234.706.97
2026Q3S2026-07-224026.234.706.97
2026Q3S2026-07-084036.234.706.97
2026Q3S2026-05-154036.764.708.70
2026Q3S2026-05-114027.086.008.70
2026Q3S2026-05-084037.086.008.70
2026Q3S2026-04-294017.146.008.80
2026Q3S2026-03-044037.146.008.80
2026Q3S2026-02-253037.266.008.80
2026Q3S2026-02-163028.696.9710.30

Estimate history

EPS, annual-0.28-0.143-0.105-0.4160.251.4590.030.406-0.473-0.9427
Period201720182019202020212022202320242025TTM
EPS, quarterly0.0990.0740.094-0.157-0.064-0.058-0.194-0.16-0.532
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Sales, annual20.58826.42727.2639.57727.04244.53224.40541.80727.48217.51
Period201720182019202020212022202320242025TTM
Sales, quarterly9.2398.83913.0678.3447.3156.8844.9393.3942.29
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Shares, annual13.48916.11216.48616.49116.61716.3916.37416.49516.46416.462
Period201720182019202020212022202320242025MRQ
Shares, quarterly16.39516.3916.49516.44516.4416.4416.46416.46216.462
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue17.5127.4841.8124.4144.5327.049.5827.2626.43
Cost of Goods Sold Incl. D&A11.1415.6217.3810.3514.9010.054.339.719.52
Gross Profit6.3711.8724.4314.0629.6316.995.2517.5616.91
Selling, General and Administrative Excl. Other19.6322.1716.3414.4414.8012.8713.4819.5318.92
Research and Development6.407.784.223.683.463.444.166.426.26
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income-13.26-10.318.09-0.3814.834.12-8.23-1.97-2.01
Interest Expense0.000.000.000.000.000.000.010.000.16
Unusual Expense0.000.000.000.000.000.00-1.35--
Net Income Before Taxes-12.70-9.629.020.6527.994.12-6.84-1.70-2.02
Income Taxes2.79-1.912.380.173.750.000.000.000.00
Consolidated Net Income-15.48-7.726.650.4824.244.12-6.84-1.70-2.02
Net Income From Continuing Operations-15.48-7.726.650.4824.244.12-6.84-1.70-2.02
Net Income-15.48-7.726.650.4824.244.12-6.84-1.70-2.02
EPS (Recurring)-0.94-0.470.410.031.460.25-0.47-0.10-0.14
EPS (Basic, Before Extraordinaries)-0.94-0.470.410.031.470.25-0.42-0.10-0.14
EPS (Diluted)-0.94-0.470.410.031.460.25-0.42-0.10-0.14
EBITDA-12.63-9.688.520.0315.154.73-7.51-1.42-1.35
Non-Operating Income (Expense)0.560.680.931.0313.160.000.070.270.14
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense0.230.240.240.280.150.410.390.620.98
Price To Earnings Ratio--12.11-4.6229.17---
Price To Sales Ratio2.842.362.711.572.774.416.622.113.96
Gross Margin36.3943.1858.4457.6166.5362.8254.8164.4063.99
Operating Margin-75.72-37.5019.35-1.5733.3015.24-85.98-7.22-7.59
Net Margin-88.45-28.0915.901.9954.4415.23-71.37-6.24-7.65
Shares Outstanding16.4616.4616.5016.3716.3916.6216.4916.4916.11
Market Capitalization54.3254.32113.4238.66123.26119.9863.7058.40119.19

Income statement, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q12024Q42024Q3
Total Revenue2.293.394.946.887.328.3413.078.84
Cost of Goods Sold Incl. D&A1.522.403.044.174.413.995.963.60
Gross Profit0.770.991.902.712.904.357.115.24
Selling, General and Administrative Excl. Other3.955.355.055.284.857.005.383.75
Research and Development1.111.591.881.821.472.611.560.86
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-3.18-4.36-3.15-2.57-1.94-2.651.731.50
Interest Expense0.000.000.000.000.000.000.000.00
Unusual Expense0.000.000.000.000.000.000.000.00
Net Income Before Taxes-3.06-4.23-2.99-2.41-1.76-2.461.961.77
Income Taxes5.69-1.610.17-1.47-0.720.110.410.56
Consolidated Net Income-8.75-2.63-3.17-0.94-1.04-2.571.551.22
Net Income From Continuing Operations-8.75-2.63-3.17-0.94-1.04-2.571.551.22
Net Income-8.75-2.63-3.17-0.94-1.04-2.571.551.22
EPS (Recurring)-0.53-0.16-0.19-0.06-0.06-0.160.090.07
EPS (Basic, Before Extraordinaries)-0.53-0.16-0.19-0.06-0.06-0.160.090.07
EPS (Diluted)-0.53-0.16-0.19-0.06-0.06-0.160.090.07
EBITDA-3.03-4.20-2.98-2.41-1.78-2.501.861.60
Non-Operating Income (Expense)0.120.120.160.160.180.180.230.28
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense0.060.060.060.060.060.060.100.04
Price To Earnings Ratio----43.1311.6312.1114.22
Price To Sales Ratio2.842.912.361.442.061.962.722.30
Gross Margin33.5829.2038.4339.4139.6952.1854.3959.28
Operating Margin-138.86-128.40-63.76-37.32-26.56-31.7113.2116.91
Net Margin-382.05-77.37-64.12-13.70-14.18-30.8211.8313.75
Shares Outstanding16.4616.4616.4616.4416.4416.4516.5016.39
Market Capitalization54.3265.5265.3751.6277.9578.02113.4295.06

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments22.0822.0623.1525.5214.5214.9115.4915.3811.19
Short Term Receivables6.0419.7310.6417.3012.133.7814.0113.154.96
Inventories16.0913.4414.853.501.764.433.001.631.17
Other Current Assets1.681.510.896.922.842.061.511.750.57
Total Current Assets45.8956.7449.5353.2431.2525.1734.0031.9017.89
Net Property, Plant & Equipment2.432.581.241.240.772.432.480.890.39
Total Investments and Advances0.000.000.000.000.000.000.000.000.00
Intangible Assets---0.050.150.340.340.430.53
Deferred Tax Assets4.092.222.161.73-----
Other Assets0.640.650.800.490.070.070.100.020.02
Total Assets53.0562.1953.7356.7532.2428.0136.9233.2518.84
Short Term Debt Incl. Current Port. of LT Debt0.260.200.190.190.230.300.310.000.00
Accounts Payable3.344.812.795.524.062.874.785.174.07
Income Tax Payable-0.000.040.89-----
Other Current Liabilities1.120.871.201.101.681.681.380.860.80
Total Current Liabilities4.725.884.217.705.964.866.476.024.87
Long Term Debt0.210.400.600.830.001.081.120.002.21
Provision for Risks Charges0.000.000.000.000.000.000.000.000.00
Deferred Tax Liabilities0.010.020.020.01-----
Other Liabilities0.010.060.060.140.260.581.340.770.07
Total Liabilities4.956.364.888.686.226.518.926.797.15
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity48.1055.8348.8448.0726.0221.5028.0026.4611.68
Total Shareholders Equity48.1055.8348.8448.0726.0221.5028.0026.4611.68
Accumulated Minority Interest0.000.000.000.000.000.000.000.000.00
Total Equity48.1055.8348.8448.0726.0221.5028.0026.4611.68
Total Liabilities & Stockholders Equity53.0562.1953.7356.7532.2428.0136.9233.2518.84
Book Value Per Share2.923.382.982.931.571.301.701.640.87
Tangible Book Value Per Share2.923.382.982.931.561.281.681.620.83
Full-Time Employees605435423742534845
Price to Book Ratio1.472.100.872.614.612.962.084.515.81
Return on Assets-13.4011.470.8854.4913.67-21.05-4.84-7.77-19.64
Return on Equity-14.8512.701.0065.4517.34-27.62-6.24-10.61-27.53
Return on Invested Capital-15.9811.820.9849.5815.83-30.28-5.84-7.64-26.70
Quick Ratio6.317.368.236.464.944.274.795.033.43
Current Ratio9.729.6411.766.925.245.185.265.303.68

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income-15.48-7.726.650.4824.244.12-6.84-1.70-2.02
Depreciation0.630.630.430.460.320.610.720.550.66
Other Funds (Non Cash)0.830.840.700.90-11.531.120.121.351.09
Funds from Operations-11.21-8.137.721.4211.325.85-6.000.20-0.27
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital4.428.66-8.55-3.56-12.73-6.145.56-2.30-8.29
Income Taxes Payable-0.00-0.04-0.850.89----
Cash from Operating Activities-6.800.53-0.83-2.15-1.41-0.29-0.43-2.11-8.56
Capital Expenditures-0.17-0.20-0.28-0.23-0.16-0.13-0.36-0.40-0.85
Net Assets From Acquisitions0.000.000.000.000.000.000.00--
Sale of Fixed Assets and Businesses0.000.000.000.0415.000.260.00--
Purchase or Sale of Investments0.000.000.000.000.000.007.39-4.50-1.79
Purchase of Investments0.000.000.000.000.000.000.00-7.80-2.89
Sale Or Maturity of Investments0.000.000.000.000.000.007.393.301.10
Other Uses0.000.000.000.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.000.000.000.00
Cash from Investing Activities-0.17-0.20-0.28-0.1914.840.137.03-4.90-2.64
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock0.00-0.300.070.02-2.270.000.002.7415.94
Repurchase of Common Pref Stock0.00-0.300.00-0.03-3.000.000.000.000.00
Sale of Common Pref Stock0.000.000.070.050.730.000.002.7415.94
Proceedsfrom Stock Options0.000.000.000.000.000.000.000.0015.85
Issuance or Reduction of Debt, Net0.000.000.000.00-0.05-0.220.270.00-2.21
Change in Long Term Debt0.000.000.000.00-0.05-0.220.270.00-2.21
Issuance of Long Term Debt0.000.000.000.000.000.000.270.000.00
Reduction of Long Term Debt0.000.000.000.00-0.05-0.220.000.00-2.21
Net Financing Active Other Cash Flow-0.01-0.01-0.05-0.06-0.11-0.01-0.06-0.12-0.12
Other Financing Activities Uses-0.01-0.01-0.05-0.06-0.11-0.01-0.06-0.12-0.12
Cash from Financing Activities-0.01-0.300.01-0.04-2.43-0.230.212.6213.60
Net Change in Cash-6.980.03-1.09-2.3711.00-0.396.81-4.382.40
Free Cash Flow-6.970.33-1.11-2.37-1.57-0.41-0.79-2.51-9.42
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow-195.73-------
Deferred Taxes & Investment Tax Credit--1.88-0.06-0.43-1.710.000.000.000.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q1
Cash & Short Term Investments15.1918.3322.0824.4522.1619.07
Short Term Receivables1.683.586.049.3412.6218.02
Inventories19.0718.9816.0914.3815.0915.57
Other Current Assets1.751.711.682.042.351.53
Total Current Assets37.6842.5945.8950.2052.2254.20
Net Property, Plant & Equipment3.082.702.433.043.293.31
Total Investments and Advances0.000.000.000.000.000.00
Deferred Tax Assets0.005.694.094.242.812.09
Other Assets0.510.570.640.820.540.62
Total Assets41.2651.5553.0558.3058.8560.21
Short Term Debt Incl. Current Port. of LT Debt0.270.270.260.260.250.25
Accounts Payable3.174.693.345.625.375.63
Other Current Liabilities0.890.901.120.930.800.84
Total Current Liabilities4.335.864.726.806.416.72
Long Term Debt0.070.140.210.280.340.41
Provision for Risks Charges0.000.000.000.000.000.00
Deferred Tax Liabilities--0.01---
Other Liabilities0.000.000.010.020.030.04
Total Liabilities4.406.004.957.106.797.18
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity36.8645.5448.1051.1952.0653.03
Total Shareholders Equity36.8645.5448.1051.1952.0653.03
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity36.8645.5448.1051.1952.0653.03
Total Liabilities & Stockholders Equity41.2651.5553.0558.3058.8560.21
Book Value Per Share2.242.772.923.113.173.22
Tangible Book Value Per Share2.242.772.923.113.173.22
Full-Time Employees--60---
Price to Book Ratio1.471.361.280.991.471.40
Return on Assets-30.94-13.91-13.40-5.09-1.453.07
Return on Equity-34.83-15.77-14.85-5.71-1.623.46
Return on Invested Capital-23.69-5.75-6.56-1.83-1.98-4.81
Quick Ratio4.304.036.315.275.795.74
Current Ratio8.717.279.727.388.148.06

Cash flow, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q1
Net Income-8.75-2.63-3.17-0.94-1.04-2.57
Depreciation0.150.160.160.160.160.14
Other Funds (Non Cash)0.130.150.170.390.160.12
Funds from Operations-2.79-3.93-2.67-1.83-1.44-2.19
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital-0.340.170.474.124.56-0.48
Income Taxes Payable--0.000.00--
Cash from Operating Activities-3.13-3.75-2.212.293.12-2.68
Capital Expenditures-0.01-0.00-0.16-0.00-0.03-0.01
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments0.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities-0.01-0.00-0.16-0.00-0.03-0.01
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock0.000.000.000.000.00-0.30
Repurchase of Common Pref Stock0.000.000.000.000.00-0.30
Sale of Common Pref Stock0.000.000.000.000.000.00
Proceedsfrom Stock Options0.000.000.000.000.000.00
Issuance or Reduction of Debt, Net0.000.000.000.000.000.00
Change in Long Term Debt0.000.000.000.000.000.00
Issuance of Long Term Debt0.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.00
Net Financing Active Other Cash Flow0.000.00-0.010.000.000.00
Other Financing Activities Uses0.000.00-0.010.000.000.00
Cash from Financing Activities0.000.00-0.010.000.00-0.30
Net Change in Cash-3.14-3.76-2.372.293.09-2.98
Free Cash Flow-3.14-3.76-2.372.293.09-2.68
Price to Free Cash Flow--195.7223.6522.1516.70

Revenue breakdown

Product2024: 36.40M 2025: 19.76M 2024: 247.00K 2025: 1.72M
Service2024: 1.96M 2025: 2.54M 2024: 3.20M 2025: 3.46M
China2024: 1.45M 2025: 2.03M
Other2024: 182.00K 2025: 90.00K
United States2024: 40.18M 2025: 25.36M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-301.66%0.2M13.4M30.53K
2026-10-151.72%0.2M13.4M28.94K
2026-09-301.70%0.2M13.4M30.36K
2026-09-151.70%0.2M13.4M32.93K
2026-08-311.61%0.2M13.4M40.36K
2026-08-141.54%0.2M13.6M38.69K
2026-07-311.52%0.2M13.6M56.88K
2026-07-151.49%0.2M13.6M59.87K
2026-06-301.48%0.2M13.6M61.38K
2026-06-151.42%0.2M13.6M60.16K
2026-05-291.48%0.2M13.6M65.28K
2026-05-151.51%0.2M13.6M68.04K
2026-04-302.28%0.3M13.6M66.69K
2026-04-152.86%0.4M14.8M78.98K
2026-03-312.49%0.4M14.8M93.17K
2026-03-132.68%0.4M14.8M99.13K
2026-02-273.28%0.5M14.8M92.19K
2026-02-133.49%0.5M14.7M94.74K
2026-01-303.93%0.6M14.7M116.52K
2026-01-153.34%0.5M14.7M109.60K

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call1.001.754.600.000.0000.000.000.970-0.0370.000
call2.000.903.600.000.0000.000.000.855-0.0570.001
call3.000.001.050.354.2391550.000.707-0.0490.002
call4.000.000.550.253.9092250.000.489-0.0440.002
call5.000.000.950.244.7382.000.000.435-0.0550.002
call6.000.000.950.005.4940.000.000.405-0.0620.002
put1.000.000.750.0018.6500.000.00-0.030-0.0370.000
put2.000.000.750.058.7164050.00-0.142-0.0580.001
put3.000.000.750.344.8122.000.00-0.292-0.0490.002
put4.000.051.350.654.4560.000.00-0.505-0.0420.002
put5.001.403.301.8510.2886.000.00-0.565-0.0540.002
put6.002.103.302.806.0671.000.00-0.596-0.0620.002

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-08-314Statement of changes in beneficial ownership of securities2026-08-28SEC
2026-08-284Statement of changes in beneficial ownership of securities2026-08-26SEC
2026-08-254Statement of changes in beneficial ownership of securities2026-08-24SEC
2026-08-244Statement of changes in beneficial ownership of securities2026-08-20SEC
2026-08-244Statement of changes in beneficial ownership of securities2026-08-20SEC
2026-08-1410-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-138-KCurrent report2026-08-13SEC
2026-06-058-KCurrent report2026-06-02SEC
2026-06-028-KCurrent report2026-05-29SEC
2026-05-18SDSpecialized Disclosure ReportSEC
2026-05-1310-QQuarterly report pursuant to Section 13 or 15(d)2026-03-31SEC
2026-05-124Statement of changes in beneficial ownership of securities2026-05-12SEC
2026-05-078-KCurrent report2026-05-07SEC
2026-04-29DEF 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-05-29SEC
2026-04-234/A2025-11-13SEC
2026-04-223/A2023-01-03SEC
2026-04-224/A2023-12-19SEC
2026-04-224/A2022-07-21SEC
2026-03-0410-KAnnual report pursuant to Section 13 or 15(d)2025-12-31SEC
2026-02-264Statement of changes in beneficial ownership of securities2026-02-24SEC
2026-02-183Initial statement of beneficial ownership of securities2026-01-05SEC
2026-02-128-KCurrent report2026-02-12SEC
2026-01-208-KCurrent report2026-01-13SEC
2026-01-128-KCurrent report2026-01-05SEC
2025-12-164Statement of changes in beneficial ownership of securities2025-12-12SEC
2025-12-164/A2025-11-18SEC
2025-11-214Statement of changes in beneficial ownership of securities2025-11-21SEC
2025-11-204Statement of changes in beneficial ownership of securities2025-11-13SEC
2025-11-203Initial statement of beneficial ownership of securities2025-11-10SEC
2025-11-194Statement of changes in beneficial ownership of securities2025-11-18SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-08563.54K800
2026-070000
2026-060000
2026-055.00K100
2026-040000
2026-030000
2026-027.62K100
2026-010000
2025-120000
2025-11147.57K500

Institutional holders

Manager% owned
Pacific Ridge Capital Partners, LLC4.80%
VANGUARD CAPITAL MANAGEMENT LLC4.01%
DIMENSIONAL FUND ADVISORS LP1.83%
Divisadero Street Capital Management, LP1.69%
RENAISSANCE TECHNOLOGIES LLC1.47%
GEODE CAPITAL MANAGEMENT, LLC0.94%
Sachetta, LLC0.92%
Greenline Wealth Management LLC0.90%
UBS Group AG0.87%
North Star Investment Management Corp.0.76%

Funds

Fund% owned
VANGUARD TOTAL STOCK MARKET INDEX FUND3.00%
Adara Smaller Companies Fund1.89%
VANGUARD EXTENDED MARKET INDEX FUND0.94%
M3Sixty Income and Opportunity Fund0.80%
North Star Micro Cap Fund0.76%
U.S. SMALL CAP PORTFOLIO0.46%
Fidelity Extended Market Index Fund0.43%
iShares Micro-Cap ETF0.28%
U.S. SMALL CAP VALUE PORTFOLIO0.27%
Dimensional U.S. Small Cap ETF0.18%

OakChart. SRTS. Cached 15 minutes.